AXDX — Accelerate Diagnostics Balance Sheet
0.000.00%
Last trade - 00:00
- $18.61m
- $43.06m
- $12.06m
- 33
- 27
- 57
- 33
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 108 | 68.3 | 63.6 | 45.6 | 13.2 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 3.22 | 1.55 | 2.32 | 2.42 | 2.62 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 122 | 82 | 73.3 | 56 | 24.5 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 11.8 | 9.32 | 7.9 | 7.76 | 5.08 |
Other Long Term Assets | |||||
Total Assets | 134 | 93.4 | 83 | 65 | 31.4 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 8.16 | 6.97 | 6.95 | 66.6 | 12 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 142 | 156 | 118 | 87.3 | 51.3 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | -7.38 | -62.8 | -35.1 | -22.3 | -19.9 |
Total Liabilities & Shareholders' Equity | 134 | 93.4 | 83 | 65 | 31.4 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |